PATENT CLAIM ANALYSIS

Application Number: 16054073
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["514", "395000"]

Abstract:
A method for treating cancer in patients with creatinine clearance of 15 mL/min or more and less than 30 mL/min, including dividing a combination drug containing α,α,α-trifluorothymidine (FTD) and 5-chloro-6-[(2-iminopyrrolidine-1-yl)methyl]pyrimidine-2,4(1H,3H)-dione hydrochloride in a molar ratio of 1:0.5, in a dose of 30 to 50 mg/m 2 /day as FTD-equivalent, into two to four times a day, and orally administering it to the patient.

Claim (Index 7):
The method for treating cancer according to  claim 1 , wherein the cancer is large bowel cancer.

Metadata:
- Claim Count in Document: 82.0
- Percentile: 96.0
- Lexical Diversity: 1.37097
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15301807', '14916878', '14780269', '14779759', '11405348']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7924229196285372
- 35 USC 102 Novelty (BERT): 0.5023663721271162
- Combined Prediction Score: 0.7634172648783951
- Mean Citation Score: 222.27335
- Max Citation Score: 227.03183
- Similarity Product: 148.45095054740906

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test